These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7846194)

  • 1. Atypical antipsychotics, clozapine and sulpiride do not antagonise amphetamine-induced stereotyped locomotion.
    Moore S; Kenyon P
    Psychopharmacology (Berl); 1994 Feb; 114(1):123-30. PubMed ID: 7846194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locomotor stereotypy is produced by methylphenidate and amfonelic acid and reduced by haloperidol but not clozapine or thioridazine.
    Mueller K
    Pharmacol Biochem Behav; 1993 May; 45(1):71-6. PubMed ID: 8100075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of sulpiride and metoclopramide on amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Eur J Pharmacol; 1985 Feb; 109(1):81-9. PubMed ID: 4039669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
    Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
    Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT; Rebec GV
    Pharmacol Biochem Behav; 1988 Nov; 31(3):519-22. PubMed ID: 3251235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of haloperidol and clozapine on neuropeptide Y-like immunoreactivity in the nucleus accumbens and striatum of rats pretreated with psychostimulants.
    Obuchowicz E; Herman ZS
    Neuropeptides; 2003 Feb; 37(1):17-24. PubMed ID: 12637031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lever-release version of the conditioned avoidance response paradigm: effects of haloperidol, clozapine, sulpiride, and BMY-14802.
    White IM; Ciancone MT; Haracz JL; Rebec GV
    Pharmacol Biochem Behav; 1992 Jan; 41(1):29-35. PubMed ID: 1347175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Another look at amphetamine-induced stereotyped locomotor activity in rats using a new statistic to measure locomotor stereotypy.
    Mueller K; Hollingsworth EM; Cross DR
    Psychopharmacology (Berl); 1989; 97(1):74-9. PubMed ID: 2496430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):69-74. PubMed ID: 1172258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats.
    Gattaz WF; Schummer B; Behrens S
    J Neural Transm Gen Sect; 1994; 96(3):227-32. PubMed ID: 7826573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801.
    Ninan I; Kulkarni SK
    Indian J Physiol Pharmacol; 1998 Jul; 42(3):375-82. PubMed ID: 9741652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of kainic acid lesions on locomotor responses to haloperidol and clozapine.
    Bardgett ME; Jackson JL; Taylor BM; Csernansky JG
    Psychopharmacology (Berl); 1998 Feb; 135(3):270-8. PubMed ID: 9498730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat.
    Mobini S; Chiang TJ; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2000 Sep; 152(1):47-54. PubMed ID: 11041315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors.
    Maurel-Remy S; Bervoets K; Millan MJ
    Eur J Pharmacol; 1995 Jul; 280(2):R9-11. PubMed ID: 7589172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1639-43. PubMed ID: 2874567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitivity to amphetamine following long-term treatment with clozapine or haloperidol.
    Rebec GV; Peirson EE; McPherson FA; Brugge K
    Psychopharmacology (Berl); 1982; 77(4):360-6. PubMed ID: 6813898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of AP-5- and amphetamine-induced behaviour by timelotem as compared with clozapine and haloperidol.
    Schmidt WJ; Krähling H; Ruhland M
    Life Sci; 1987 Oct; 41(16):1909-14. PubMed ID: 2889124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats.
    Meng ZH; Feldpaush DL; Merchant KM
    Brain Res Mol Brain Res; 1998 Oct; 61(1-2):39-50. PubMed ID: 9795122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
    Halperin R; Guerin JJ; Davis KL
    Psychopharmacology (Berl); 1989; 98(3):386-91. PubMed ID: 2568659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.